Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study

OBJECTIVE: To observe the safety and short-term efficacy of apatinib in the treatment of recurrent, metastatic cervical cancer in patients who have already received more than two kinds of comprehensive treatment. METHODS: Forty-eight patients with recurrent or metastatic cervical cancer after radiot...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yan, Cheng, Huijun, Wang, Li, Yu, Xiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918889/
https://www.ncbi.nlm.nih.gov/pubmed/31788992
http://dx.doi.org/10.3802/jgo.2020.31.e2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918889/
https://www.ncbi.nlm.nih.gov/pubmed/31788992
http://dx.doi.org/10.3802/jgo.2020.31.e2

Ejemplares similares